Explore cutting-edge biotech research, breakthroughs, and its impact on industries.
Biotechnology
Remember when DeepMind's AlphaFold cracked the decades-old protein folding problem and walked off with a Nobel Prize? That was just the beginning. Now, the Google-owned AI lab is taking aim at an even tougher challenge: deciphering the 98% of your genome we still barely understand. Meet AlphaGenome, DeepMind’
Biotechnology
Elon Musk’s brain-computer interface startup, Neuralink, has raised $600 million in a new funding round, pushing its pre-money valuation to $9 billion. The round marks a significant leap in valuation for the company, which was reportedly worth $5 billion less than a year ago. The identities of the investors
Biotechnology
Samsung’s venture capital arm is preparing to invest in California-based medical device startup Exo, as part of a funding round that could reach $100 million. The round is reportedly being led by Sands Capital, Bold Capital, and Qubit Health Capital. Notably, Qubit Health’s chairman, former Medtronic CEO Omar
Biotechnology
Pharmaceutical giant Regeneron announced Monday that it will acquire genetic testing company 23andMe for $256 million, following a court-supervised bankruptcy auction. The deal, if approved, will grant Regeneron ownership of 23andMe’s genomics service and a massive trove of personal and genetic data from roughly 15 million customers. The acquisition
Biotechnology
Biotech startup NewLimit, which is focused on extending healthy human lifespan through cellular reprogramming, has raised a $130 million Series B round led by Kleiner Perkins. The round also included new investors Nat Friedman, Daniel Gross, and Khosla Ventures, along with returning backers like Founders Fund, Dimension Capital, Elad Gil,
Biotechnology
Twelve thousand years after they vanished from the face of the Earth, dire wolves—once apex predators of the Ice Age—have returned. In a stunning scientific breakthrough, Colossal Biosciences, the ambitious de-extinction company known for its efforts to resurrect the woolly mammoth, announced the successful birth of three dire
Biotechnology
Isomorphic Labs, the artificial intelligence-driven drug discovery startup spun out of DeepMind, has secured $600 million in its first-ever external funding round. The financing, led by Thrive Capital with participation from Alphabet and its venture arm GV, marks a significant milestone for the Alphabet-owned company as it scales its efforts
Biotechnology
Once heralded as a trailblazer in consumer genetics, 23andMe has filed for Chapter 11 bankruptcy protection, marking a dramatic fall from its former $6 billion valuation. The filing was made Sunday night in Missouri federal court, capping off a tumultuous period for the company marked by financial struggles, failed business
Artificial Intelligence (AI)
OpenAI, known for its transformative AI technologies, has ventured into the world of protein engineering with a groundbreaking model capable of improving stem cell generation. This marks a significant step in AI’s role in advancing scientific discovery and a bold move toward OpenAI’s broader vision of artificial general
Biotechnology
Researchers at Caltech have developed groundbreaking bioresorbable acoustic microrobots (BAM)—tiny, bubble-like robots capable of precisely delivering therapeutic drugs within the body. In preclinical tests, these microrobots successfully shrank bladder tumors in mice, marking a significant advancement in targeted drug delivery and precision medicine. How the Microrobots Work These spherical
Medicine
Diagnostic medicine is taking a step into the future with an innovation straight out of cyberpunk fiction. Scientists at the University of Texas at Austin have unveiled groundbreaking technology: temporary electronic tattoos capable of monitoring brain activity. This advancement could one day make diagnosing neurological conditions faster, more comfortable, and
Science
Artificial intelligence (AI) is increasingly becoming an active collaborator in scientific research, moving beyond its traditional role as a supportive tool. A notable example is the 'Virtual Lab' developed by Stanford University, where AI agents assume roles such as principal investigator, scientist, and scientific critic to collaboratively address